New treatment option for Contact Lens Comfort
Official title Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses
ClinicalTrials.gov ID: NCT06955403
What this study is testing
- What it's testing
- Determine the likelihood of successfully refitting a satisfied AOA CL wearers into P7A CLs
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40. Healthy volunteers may be eligible.
You may be able to join if
- Adults, 18- to 40-year-old, AOA CL wearers with best-corrected 20/20 visual acuity or better.
- Participants will be required to have worn AOA CLs for at least 3 months in the past year and currently wearing these CLs.
- All participants will be required to have a CLDEQ-8 score \<12 while wearing their habitual CLs (AOA CLs) and to indicate that they are satisfied...
- Participants will be required to be able to wear P7A CLs (astigmatism ≥0.75D OD/OS).
- Astigmatism ranging from 0.75 D to 2.50 D in each eye
You likely can't join if
- \- Have presbyopia and/or need a reading add as determined during their initial manifest refraction
- Have worn P7A in the past
- Are past rigid CL wearers
- Have a history of being diagnosed with dry eye or ocular allergies
- Have known systemic health conditions that are thought to alter tear film physiology
- Have a history of viral eye disease
See the full eligibility criteria
- Adults, 18- to 40-year-old, AOA CL wearers with best-corrected 20/20 visual acuity or better.
- Participants will be required to have worn AOA CLs for at least 3 months in the past year and currently wearing these CLs.
- All participants will be required to have a CLDEQ-8 score \<12 while wearing their habitual CLs (AOA CLs) and to indicate that they are satisfied with AOA CLs (Yes/No).
- Participants will be required to be able to wear P7A CLs (astigmatism ≥0.75D OD/OS).
- Astigmatism ranging from 0.75 D to 2.50 D in each eye
- Participants will be required to wear the study CLs for ≥13 hours with no overnight wear
- Participants will be willing to wear the CL every day of the week, except during the washout period
- Participants will be required to provide a glasses prescription that is less than 3 years old
- \- Have presbyopia and/or need a reading add as determined during their initial manifest refraction
- Have worn P7A in the past
- Are past rigid CL wearers
- Have a history of being diagnosed with dry eye or ocular allergies
- Have known systemic health conditions that are thought to alter tear film physiology
- Have a history of viral eye disease
- Have a history of ocular surgery
- Have a history of severe ocular trauma
- Have a history of corneal dystrophies or degenerations
- Have active ocular infection or inflammation
- Are currently using isotretinoin-derivatives or ocular medications
- Are pregnant or breast feeding
The study team makes the final eligibility decision.
Where it's taking place
- Memphis, Tennessee, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Memphis, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.